Is Palantir Stock Overvalued or Undervalued? The Answer May Surprise You.

Palantir trades at about 78x trailing revenue and 111x forward earnings, reflecting a rich valuation, but the article argues the premium is supported by accelerating growth and expanding margins. Revenue growth has improved from 17%, 29%, and 56% over the past three years, and analysts now model 62% top-line growth this year. The business is benefiting from AI-driven automation and faster-growing commercial demand, though the stock remains expensive on traditional metrics.

Analysis

PLTR is still being valued like a scarcity asset, not a normal large-cap software name, which means the stock’s key vulnerability is not a miss on this quarter but any slowdown in the rate of estimate revision. At these multiples, the market is paying up for duration: every incremental deceleration in growth or margin expansion has an outsized effect on implied fair value because the terminal multiple is doing most of the work. The setup is therefore asymmetric to the downside if the next few prints are merely good instead of exceptional.

The more interesting second-order effect is competitive signaling. A company that can sustain elite margins while scaling tends to pull capital and talent toward adjacent AI/enterprise software vendors, but it also raises the bar for every peer selling “AI transformation” narratives. That can support the broader AI software basket near term, yet it eventually forces weaker incumbents to spend more on product and distribution to defend share, compressing margins across the group.

The consensus is underestimating how much of the current thesis already depends on continued multiple expansion rather than fundamentals catching up. If the commercial engine keeps compounding, the stock can keep working, but the entry point matters: at this size, the next leg higher likely needs another 6-8 quarters of spotless execution plus a still-cooperative risk regime. The cleaner trade is not a blanket short; it is expressing skepticism through relative value or optionality where the downside from multiple compression is more convex than the upside from another beat.

Catalyst-wise, the risk window is months, not days: any guide that merely confirms current expectations may be enough for a de-rating if the market rotates out of momentum. Conversely, a large upside surprise on commercial bookings or operating leverage can extend the run for another 1-2 quarters, but the burden of proof keeps rising. In short, this is a quality compounder with crowded expectations, not a cheap re-rating story.

Key Decisions for Investors

• Avoid initiating fresh outright longs in PLTR at current levels; if already long, trim 20-30% into strength and keep the remainder only if you can tolerate a 15-20% drawdown from multiple compression.
• Express a relative-value view: long NVDA / short PLTR for 3-6 months, targeting a reversion toward more balanced growth-adjusted valuation if AI enthusiasm broadens away from software scarcity names.
• For investors wanting exposure to enterprise AI upside, use call spreads rather than stock: buy PLTR 6-9 month call spreads with strikes roughly 10-15% above spot to cap premium burn while preserving convexity on another beat-and-raise.
• Watch next two earnings cycles as the critical confirmation window; if revenue acceleration or commercial growth decelerates for even one quarter, reduce exposure aggressively because the stock is priced for uninterrupted perfection.
• If a short is desired, use a pairs trade against a more reasonably valued profitable software name rather than an outright PLTR short, since momentum and index ownership can keep the stock elevated longer than fundamentals would suggest.